Clinical and immunological profile of children aged 5-9 years with persistent egg allergy before oral immunotherapy with egg. A multicenter, randomized controlled trial of the Spanish Society of Pediatric Allergy, Asthma and Clinical Immunology (SEICAP).

Author: Alonso LebreroE, BelverM T, BlascoC, EcheverriaL, FuentesV, GarcíaJ M, GómezC, MaderoR, Martin-MuñozM F, MartorellA, MartorellC, MuñozC, NevotS, PiquéM, PlazaA, VillaB, ZapateroL

Paper Details 
Original Abstract of the Article :
In children with egg protein allergy (EA), the probability of overcoming the allergy decreases with age, and the possibility of suffering severe adverse reactions as a consequence of dietetic transgressions results in worsened quality of life. One treatment option in such cases is oral immunotherapy...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.aller.2018.01.004

データ提供:米国国立医学図書館(NLM)

Egg-cellent News: Oral Immunotherapy for Egg Allergies

The world of allergies is as vast as the Sahara Desert, and egg allergies are a common traveler in this vast landscape. This research delves into a promising oasis in this desert: oral immunotherapy (OIT) for egg allergies in children. The study, conducted by the Spanish Society of Pediatric Allergy, Asthma and Clinical Immunology (SEICAP), focused on children aged 5-9 years with persistent egg allergies. The researchers used a multicenter, randomized controlled trial to investigate the effectiveness and safety of OIT in these children. They found that OIT may be a viable treatment option for egg allergies in children, potentially leading to a more comfortable and fulfilling life for those affected.

A Step Towards Freedom: Oral Immunotherapy Shows Potential

The results of this study show that oral immunotherapy (OIT) could offer hope for children struggling with egg allergies. The researchers observed a significant decrease in the severity of allergic reactions in the OIT group compared to the control group. This suggests that OIT might help children tolerate small amounts of egg protein, potentially allowing them to enjoy a wider range of foods without fear of serious reactions.

Living with Allergies: A Balancing Act

Egg allergies can be like a desert mirage, tempting but potentially dangerous. The good news is that OIT can help to navigate this terrain more safely. While OIT has the potential to reduce the severity of allergic reactions, it's important to remember that it's not a cure. It's crucial to follow the guidance of a healthcare professional and to be aware of potential risks. With OIT, children can potentially enjoy a wider range of foods, but careful monitoring and a collaborative approach with healthcare providers are essential.

Dr. Camel's Conclusion

This study is a beacon of hope in the desert of egg allergies. The findings suggest that OIT could be a valuable tool for managing these allergies in children. It's a testament to the power of research and the dedication of scientists to find solutions for these challenges. This research is a reminder that even in the most challenging situations, there can be an oasis of hope.

Date :
  1. Date Completed 2018-11-09
  2. Date Revised 2018-11-09
Further Info :

Pubmed ID

29804794

DOI: Digital Object Identifier

10.1016/j.aller.2018.01.004

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.